Transcatheter aortic valve implantation with the repositionable and fully retrievable Lotus Valve System^TM

Transcatheter aortic valve implantation (TAVI) has become a therapeutic alternative for patients presenting with severe symptomatic aortic stenosis and considered either at high (1,2) or intermediate preoperative risk (3,4) for surgical aortic valve replacement (SAVR).